Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jun;79(6):388-395.
doi: 10.1136/oemed-2021-107487. Epub 2021 Nov 5.

Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities

Jeadran Nevardo Malagón-Rojas  1   2 , Marcela Mercado-Reyes  3 , Yezith G Toloza-Pérez  2 , Eliana L Parra Barrera  2 , Marien Palma  2 , Esperanza Muñoz  4 , Ronald López  2 , Julia Almentero  2 , Vivian V Rubio  3 , Edgar Ibáñez  5 , Eliana Téllez  2   6 , Lucy G Delgado-Murcia  7 , Claudia P Jimenez  8   9 , Diego Viasus-Pérez  10 , Marisol Galindo  3 , Luisa Lagos  2 ; Interinstitutional Support Group
Collaborators, Affiliations
Multicenter Study

Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities

Jeadran Nevardo Malagón-Rojas et al. Occup Environ Med. 2022 Jun.

Abstract

Background: Healthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia.

Methods: This study is a cross-sectional study focused on estimating the seroprevalence of SARS-CoV-2 antibodies in healthcare workers from 65 hospitals in 10 cities in Colombia during the second semester of 2020. The seroprevalence was determined using an automated immunoassay (Abbott SARS-CoV-2 CLIA IgG). The study included a survey to establish the sociodemographic variables and the risk of infection. A multivariate model was used to evaluate the association between the results of seroprevalence and risk factors.

Results: The global seroprevalence of antibodies against SARS-CoV-2 was 35% (95% Bayesian CI 33% to 37%). All the personnel reported the use of protective equipment. General services personnel and nurses presented the highest ratios of seroprevalence among the healthcare workers. Low socioeconomic strata have shown a strong association with seropositivity.

Conclusion: This study estimates the prevalence of SARS-CoV-2 infection among healthcare workers. Even though all the personnel reported the use of protective equipment, the seroprevalence in the general services personnel and nurses was high. Also, a significant difference by cities was observed.

Keywords: COVID-19; cross-sectional studies; health personnel; occupational health; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Distribution of seroprevalence by city. The figure presents in greyscale the prevalence of antibodies against SARS-CoV-2 in each city included in the study. Cities are marked with a white dot. The greater the intensity of the grey, the greater the seroprevalence was found in the city.
Figure 2
Figure 2
Seroprevalence among healthcare workers in Colombia by occupation. *Other: nutritionists, Rx technician, physiotherapist and clinical laboratory technician. The figure shows the crude and adjusted seroprevalence levels among different healthcare occupations. Seroprevalence levels were higher among nurses and general services workers.
Figure 3
Figure 3
Seroprevalence and socioeconomic stratum in Colombia. The figure presents the differences in the seroprevalence of antibodies against SARS-CoV-2 among healthcare workers from different socioeconomic levels. There is a linear trend showing higher seroprevalence levels in lower socioeconomic strata (1–3) and lower seroprevalence in higher socioeconomic strata (4–6).
See this image and copyright information in PMC

References

    1. World Health Organization . Keep health workers safe to keep patients safe: who. Available: https://www.who.int/news/item/17-09-2020-keep-health-workers-safe-to-kee... [Accessed 8 Feb 2021].
    1. Erdem H, Lucey DR. Healthcare worker infections and deaths due to COVID-19: a survey from 37 nations and a call for who to post national data on their website. Int J Infect Dis 2021;102:239–41. 10.1016/j.ijid.2020.10.064 - DOI - PMC - PubMed
    1. Venugopal U, Jilani N, Rabah S, et al. . SARS-CoV-2 seroprevalence among health care workers in a new York City Hospital: a cross-sectional analysis during the COVID-19 pandemic. Int J Infect Dis 2021;102:63–9. 10.1016/j.ijid.2020.10.036 - DOI - PMC - PubMed
    1. Kataria Y, Cole M, Duffy E, et al. . Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Sci Rep 2021;11:9694. 10.1038/s41598-021-89107-5 - DOI - PMC - PubMed
    1. Takita M, Matsumura T, Yamamoto K. Preliminary results of seroprevalence of SARS-CoV-2 at community clinics in Tokyo. Infectious Diseases 2020.

Publication types